Your browser doesn't support javascript.
loading
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.
Im, Nam Gyu; Guillaumet-Adkins, Amy; Wal, Megha; Rogers, Anna J; Frede, Julia; Havig, Claire C; Yang, Jing; Anand, Praveen; Stegmann, Sarah K; Waldschmidt, Johannes M; Sotudeh, Noori; Niu, Leili; Voisine, Jordan; Schweiger, Michal R; Grassberger, Clemens; Lohr, Jens G; Knoechel, Birgit.
Affiliation
  • Im NG; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Guillaumet-Adkins A; Harvard Medical School, Boston, Massachusetts.
  • Wal M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Rogers AJ; Institute for Translational Epigenetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Frede J; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Havig CC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yang J; Harvard Medical School, Boston, Massachusetts.
  • Anand P; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Stegmann SK; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Waldschmidt JM; Harvard Medical School, Boston, Massachusetts.
  • Sotudeh N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Niu L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Voisine J; Harvard Medical School, Boston, Massachusetts.
  • Schweiger MR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Grassberger C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lohr JG; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Knoechel B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Immunol Res ; 10(9): 1055-1068, 2022 09 01.
Article in En | MEDLINE | ID: mdl-35759797
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2022 Document type: Article Country of publication: United States